Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint) (NCT02595047) | Clinical Trial Compass
UnknownNot Applicable
Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint)
China1 participantsStarted 2013-01
Plain-language summary
The purpose of this study is to observe the feasibility and its application of autologous prefabrication for body surface tissues/oranges
Who can participate
Age range5 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* With body surface tissue or organ defects (e.g., ear, nose, bone and joint) requiring reconstruction.
Exclusion Criteria:
* evidence of infection, ischemia, ulcer or other pathological changes within the prefabricated area which defined as not suitable for tissues regeneration
* history of delayed healing, radiational therapy;
* significant renal, cardiovascular, hepatic and psychiatric diseases;
* significant medical diseases or infection (including but not limited to the carrier of hepatitis B virus or HIV);
* BMI \>30;
* history of any hematological disease, including leukopenia, thrombocytopenia, or thrombocytosis;
* Evidence of malignant diseases
* unwillingness to participate.
What they're measuring
1
Occurence of major adverse events
Timeframe: through study completion 12 months after prefabrication
Trial details
NCT IDNCT02595047
SponsorShanghai Jiao Tong University School of Medicine